TotalMarketCap

Retension Pharmaceuticals

RTSNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$127.524 M

$16.18 -0.92%

Close of 21 Oct 2026

As of 21 Oct 2026, Retension Pharmaceuticals (RTSN) has a market capitalization of $127.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →
  1. #279OrganogenesisORGO$131.2M
  2. #280Tiziana Life SciencesTLSA$128.5M
  3. #281Retension PharmaceuticalsRTSN$127.5M
  4. #282NkartaNKTX$124.6M
  5. #283Cue BiopharmaCUE$123.8M

What if Retension Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.6T

$3,631,682

Per share 224,455× higher

Bitcoin $1.69T

$214,702.91

Per share 13,270× higher

Nvidia $5.22T

$661,912.26

Per share 40,909× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Retension Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Oct 2026. Read the methodology.